导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.28% | 451/1050 |
| 近一周 | -2.02% | 475/1104 |
| 近一月 | -0.79% | 177/1102 |
| 近一季 | 3.15% | 192/1092 |
| 近半年 | 3.79% | 353/1070 |
| 近一年 | -0.12% | 595/1018 |
| 近两年 | 17.63% | 800/926 |
| 近三年 | 6.10% | 623/833 |
| 成立以来 | 154.62% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.42% 678/1070 |
-2.31% 738/1101 |
- - |
- - |
| 2025 | -5.28% 947/1065 |
-3.14% 959/1014 |
-1.68% 823/1038 |
0.41% 996/1050 |
-0.93% 493/1065 |
| 2024 | 14.83% 180/1011 |
9.18% 37/960 |
-2.65% 477/983 |
12.70% 407/991 |
-4.13% 602/1011 |
| 2023 | 1.68% 77/952 |
8.92% 147/880 |
1.00% 134/895 |
-2.06% 158/915 |
-5.63% 572/952 |
| 2022 | -10.46% 90/867 |
-15.61% 287/773 |
7.88% 358/806 |
-7.93% 140/845 |
6.82% 141/867 |
| 2021 | -2.41% 387/740 |
1.03% 106/580 |
-0.16% 546/659 |
-7.92% 448/704 |
5.07% 218/740 |
| 2020 | 67.13% 154/554 |
2.38% 106/419 |
20.35% 279/466 |
20.93% 50/517 |
12.16% 286/554 |
| 2019 | 36.23% 251/410 |
20.46% 906/1149 |
3.43% 93/1231 |
3.26% 243/390 |
5.88% 315/410 |
| 2018 | -16.81% 40/349 |
- - |
- - |
- - |
-11.49% 469/1080 |
| 2017 | 44.72% 10/285 |
- - |
- - |
- - |
- - |
| 2016 | -4.73% 43/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 嘉实新消费股票 VS. 东吴新产业精选股票A(580008) |